Matthew Davidson
Net worth: 338 612 $ as of 30/09/2026
Net worth: 338 612 $ as of 30/09/2026
Dr. Matthew Davidson is a President, Chief Executive Officer & Director at Adial Pharmaceuticals, Inc. and a President, Chief Executive & Financial Officer at Azora Therapeutics, Inc. He is on the Board of Directors at Adial Pharmaceuticals, Inc. Dr. Davidson was previously employed as a Chief Scientific Officer & Director by Verrica Pharmaceuticals, Inc. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from Stanford University School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/08/2026 | 84,442 ( 3.22% ) | 338 612 $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | Chief Executive Officer | 28/10/2026 |
Azora Therapeutics, Inc.
Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for inflammatory diseases | Chief Executive Officer | 01/03/2019 |
| Companies | Position | End |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medications to treat addiction and related disorders | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verrica Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Azora Therapeutics, Inc.
Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions